Search research articles
Contact Us
Filters
Showing results (291-300 of 523) with videos related to
Page
of 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
Edwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
The Annals of Thoracic Surgery
|
September 25, 2019
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer
Kyle G Mitchell, Marcelo V Negrao, Edwin R Parra, et al.
Science Immunology
|
June 5, 2026
Atlas of human gut-associated lymphoid tissue reveals immunomodulatory interactions of B cells
Michael J Pitcher, Xiaowen Sun, Chiara Dionisi, et al.
Journal of Immunotherapy and Precision Oncology
|
April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021
Mehmet Altan, Dawen Sui, Cai Xu, et al.
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2015
Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer
Renata Ferrarotto, Ruchitha Goonatilake, Suk Young Yoo, et al.
Oncogene
|
October 4, 2016
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
D H Peng, C Ungewiss, P Tong, et al.
Journal for Immunotherapy of Cancer
|
July 8, 2026
Unbiased avidity-based isolation of antigen-specific T cells
Amanda Montoya, Meredith L Frank, Peixin Jiang, et al.
JAMA Network Open
|
June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Molecular Cancer Research : MCR
|
November 11, 2020
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
Kavya Ramkumar, C Allison Stewart, Kasey R Cargill, et al.
Page
of 53
Search research articles
Search
Showing results (291-300 of 523) with videos related to
Sort By:
Page
of 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2016
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients
Edwin R Parra, Carmen Behrens, Jaime Rodriguez-Canales, et al.
The Annals of Thoracic Surgery
|
September 25, 2019
Lymphovascular Invasion Is Associated With Mutational Burden and PD-L1 in Resected Lung Cancer
Kyle G Mitchell, Marcelo V Negrao, Edwin R Parra, et al.
Science Immunology
|
June 5, 2026
Atlas of human gut-associated lymphoid tissue reveals immunomodulatory interactions of B cells
Michael J Pitcher, Xiaowen Sun, Chiara Dionisi, et al.
Journal of Immunotherapy and Precision Oncology
|
April 16, 2025
PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017-2021
Mehmet Altan, Dawen Sui, Cai Xu, et al.
Cancer Cell
|
November 25, 2021
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
Hongzhong Li, Yi Xiao, Qin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 25, 2015
Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer
Renata Ferrarotto, Ruchitha Goonatilake, Suk Young Yoo, et al.
Oncogene
|
October 4, 2016
ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
D H Peng, C Ungewiss, P Tong, et al.
Journal for Immunotherapy of Cancer
|
July 8, 2026
Unbiased avidity-based isolation of antigen-specific T cells
Amanda Montoya, Meredith L Frank, Peixin Jiang, et al.
JAMA Network Open
|
June 6, 2022
Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
Yufei Liu, Zhe Zhang, Waree Rinsurongkawong, et al.
Molecular Cancer Research : MCR
|
November 11, 2020
AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors
Kavya Ramkumar, C Allison Stewart, Kasey R Cargill, et al.
Page
of 53